Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Primer and probe combination and kit for detecting human pathogenic bacteria

A technology of pathogenic bacteria and kits, applied in the field of medical detection, can solve the problem that the detection sensitivity cannot reach the clinical level

Pending Publication Date: 2019-12-13
PILOT GENE TECH HANGZHOU CO LTD
View PDF2 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The detection sensitivity of the existing products for direct identification of clinical infection samples cannot meet the requirements of clinical level

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primer and probe combination and kit for detecting human pathogenic bacteria
  • Primer and probe combination and kit for detecting human pathogenic bacteria
  • Primer and probe combination and kit for detecting human pathogenic bacteria

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Embodiment 1 Primer and probe combination of the present invention, reference primer and probe combination

[0059] The sequences of primers and probes are listed in Table 1.

[0060] Table 1 Primer and Probe Combination Sequences

[0061]

[0062]

Embodiment 2

[0063] Embodiment 2 Kit of the present invention

[0064] The kit includes primers and probe combinations of the present invention in Table 1, sample extraction reagents, multiple digital PCR detection reagents, positive control substances, negative control substances, PCR chips, special oil for chips, ddH 2 O.

[0065] Among them, the negative control substance is ultrapure water, and the positive control substance is the standard substance corresponding to the target strain detected by the kit.

Embodiment 3

[0067] Utilize the kit of embodiment 2 to Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Staphylococcus epidermidis, Staphylococcus aureus, Enterococcus faecium, Staphylococcus hominis and Baumannii in 84 cases of blood samples Acinetobacter was tested. Among them, 14 were positive samples and 70 were negative samples. At the same time, the blood culture method is used to determine the infection of the sample, which is the current industry gold standard.

[0068] The detection steps are:

[0069] 1. Nucleic acid extraction:

[0070] The instruments and equipment used in the nucleic acid extraction process are shown in Table 2, and the reagents are shown in Table 3.

[0071] Table 2 Instrument and Equipment List

[0072]

[0073] Table 3 Reagent name and storage

[0074] Reagent name storage Lysate A Store at 2-8°C Proteinase K Store at 2-8°C magnetic bead suspension Store at 2-8°C Washing solution A Store at 2-8...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medical detection, and in particular, relates to a primer and probe combination and a kit for detecting human pathogenic bacteria. The kit comprises theprimer and probe combination for detecting pseudomonas aeruginosa, escherichia coli, klebsiella pneumoniae, staphylococcus epidermidis, staphylococcus aureus, enterococcus faecium, human staphylococcus and acinetobacter baumannii. According to the kit, the primer and probe combination is adopted, multiple digital PCR is combined, the pathogenic bacteria types and the target nucleic acid copy number in the detection range can be rapidly and accurately identified, the detection method has high sensitivity, and positive detection of low-copy nucleic acid fragments of pathogenic bacteria is guaranteed; meanwhile, the variety of the pathogenic bacteria or the change of the copy number of the target nucleic acid fragment in the body of a pathogenic bacteria infected patient can be dynamically monitored, the treatment effect is assisted and evaluated in time, and reference is provided for optimization of a doctor clinical scheme.

Description

technical field [0001] The invention relates to the technical field of medical detection, in particular to a combination of primers and probes and a kit for detecting human pathogenic bacteria. Background technique [0002] Human pathogenic bacteria include bacteria, viruses, spirochetes, rickettsia, chlamydia, mycoplasma, fungi and actinomycetes, etc. Generally speaking, pathogenic bacteria refer to bacteria in pathogenic microorganisms. While the vast majority of bacteria are harmless or even beneficial, a significant number can cause disease. When the human body's immunity is low or there are wounds, pathogenic bacteria can invade tissue parts, leading to blood, urine and cerebrospinal fluid infections. For example, Staphylococcus aureus and Streptococcus are also normal flora, and can often exist on the skin and nasal cavity without causing disease. However, under certain conditions, clinical patients may suffer from serious infectious diseases such as pneumonia, mening...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6851C12Q1/689C12Q1/14C12Q1/10C12Q1/06C12N15/11
CPCC12Q1/6851C12Q1/689C12Q2600/166C12Q2600/16C12Q2531/113C12Q2563/107C12Q2537/143
Inventor 朱留伟董德坤夏江
Owner PILOT GENE TECH HANGZHOU CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products